Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NORINYL 1+50 21-DAY | Allergan | N-013625 DISCN | 1982-01-01 | 1 products |
NORINYL | Allergan | N-013625 DISCN | 1982-01-01 | 1 products |
NORINYL 1+50 28-DAY | Allergan | N-016659 DISCN | 1982-01-01 | 1 products, RLD |
NORINYL 1+80 21-DAY | G.D. Searle | N-016724 DISCN | 1982-01-01 | 1 products |
NORINYL 1+80 28-DAY | G.D. Searle | N-016725 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/50 28 | Johnson & Johnson | N-016709 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 10-21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/50 21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 2-21 | Johnson & Johnson | N-012728 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/80 21 | Johnson & Johnson | N-016715 DISCN | 1982-01-01 | 1 products |
ORTHO-NOVUM 1/80 28 | Johnson & Johnson | N-016715 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ENOVID | G.D. Searle | N-010976 DISCN | 1982-01-01 | 2 products |
ENOVID-E | G.D. Searle | N-010976 DISCN | 1982-01-01 | 1 products |
ENOVID-E 21 | G.D. Searle | N-010976 DISCN | 1982-01-01 | 1 products |
ENOVID | G.D. Searle | N-010976 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OVULEN | G.D. Searle | N-016029 DISCN | 1982-01-01 | 1 products |
OVULEN-21 | G.D. Searle | N-016029 DISCN | 1982-01-01 | 1 products |
OVULEN-28 | G.D. Searle | N-016705 DISCN | 1982-01-01 | 1 products |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pelvic pain | D017699 | — | — | — | — | — | 1 | 1 | 2 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | 1 | — | 1 |
Endometriosis | D004715 | EFO_0001065 | N80 | — | — | — | 1 | — | 1 |
Chronic pain | D059350 | — | — | — | — | — | 1 | — | 1 |
Interstitial cystitis | D018856 | EFO_1000869 | N30.1 | — | — | — | 1 | — | 1 |
Visceral pain | D059265 | — | — | — | — | — | 1 | — | 1 |
Dysmenorrhea | D004412 | — | N94.6 | — | — | — | 1 | — | 1 |
Cystitis | D003556 | EFO_1000025 | N30 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | — | — | 1 | — | — | 1 |
Drug common name | Mestranol |
INN | mestranol |
Description | Mestranol is a terminal acetylenic compound that is (17alpha)-17-ethynylestra-1(10),2,4-triene substituted by a methoxy group at position 3 and a hydroxy group at position 17. It has a role as a prodrug and a xenoestrogen. It is a 17beta-hydroxy steroid, a terminal acetylenic compound and an aromatic ether. It is functionally related to a 17beta-estradiol. |
Classification | Small molecule |
Drug class | estrogens |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C |
PDB | — |
CAS-ID | 72-33-3 |
RxCUI | — |
ChEMBL ID | CHEMBL1201151 |
ChEBI ID | 6784 |
PubChem CID | 6291 |
DrugBank | DB01357 |
UNII ID | B2V233XGE7 (ChemIDplus, GSRS) |